loader
Please Wait
Applying Filters...

Looking for 4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one? Find Controlled & Modified Release used in 4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 7,507Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Alcedo Pharmachem

02 1Huzhou Sunflower Pharmaceutical

03 1Ideal Cures Pvt Ltd

04 14Kerry

05 1Kima Chemical

06 1Lonza Capsugel

07 2Novo Excipients

08 2The Dow Chemical Company

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

arrow
ISPE Aseptic Conference
Not Confirmed

04

arrow
DCAT Week
Not Confirmed
arrow
DCAT Week
Not Confirmed
blank

08

arrow
ISPE Aseptic Conference
Not Confirmed
arrow
ISPE Aseptic Conference
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

14

arrow
ISPE Aseptic Conference
Not Confirmed
arrow
ISPE Aseptic Conference
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank